Cartesian Therapeutics (NASDAQ:RNAC) just disclosed its Q4 earnings on Monday, March 9, 2026 at 07:00 AM.
Here’s a brief overview of the earnings report.
Earnings
Cartesian Therapeutics missed estimated earnings by -73.75%, reporting an EPS of $-1.39 versus an estimate of $-0.8.
Revenue was up $1.71 million from the same period last year.
Overview of Past Earnings
In the previous quarter, the company missed on EPS …